Full-Time
Posted on 6/18/2024
Computational platform for biopharmaceutical research
Mid
Remote in UK
Schrödinger provides a computational platform that aids in the research efforts of biopharmaceutical companies, academic institutions, and government laboratories around the world. Their platform offers advanced computational tools that help in drug discovery and development across various therapeutic areas. Schrödinger's products work by using sophisticated algorithms and simulations to predict how different compounds will interact, which can significantly speed up the research process. Unlike many competitors, Schrödinger not only licenses its software but also engages in collaborative research and drug discovery programs, allowing for a more integrated approach to scientific research. The company's goal is to enhance scientific research and development through its platform, ultimately leading to the discovery of new drugs and therapies.
Company Stage
IPO
Total Funding
$362.7M
Headquarters
New York City, New York
Founded
1990
Help us improve and share your feedback! Did you find this helpful?